02298nam a2200481 i 4500 on1175662700 OCoLC 20200902124616.0 m o d f cr ||||||||||| 200717s2020 dcu o f000 0 eng c 30-486 (GPO jacket number) GPO eng rda pn GPO MvI pcc n-us--- KF26 .L27 2018u 1043-C (online) Y 4.L 11/4:S.HRG.115-820 Y 4.L 11/4:S.HRG.115-820 United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author. Cost of prescription drugs (2018 June 12) The cost of prescription drugs : examining the President's blueprint 'American Patients First' to lower drug prices : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining the cost of prescription drugs, focusing on examining the President's blueprint `American Patients First' to lower drug prices, June 12, 2018. Examining the President's blueprint 'American Patients First' to lower drug prices Washington : U.S. Government Publishing Office, 2020. 1 online resource (iii, 41 pages). txt c rdamedia cr rdacarrier S. hrg. ; 115-820 Access ID (govinfo): CHRG-115shrg30486. GPO Cataloging Record Distribution Program (CRDP). Hearing witnesses: Azar II, Hon. Alex M., Secretary, Department of Health and Human Services, Washington, DC. Date of hearing: 2018-06-12. Description based on online resource; title from PDF title page (govinfo, viewed July 17, 2020). Drugs United States Cost control. Pharmaceutical policy United States. Prescription pricing United States. Legislative hearings. lcgft United States. Congress. Senate. S. hrg. ; 115-820. https://purl.fdlp.gov/GPO/gpo141550 GOVINFOHRG BIBCONEW 20200717 294909 294909